Lv1
30 积分 2023-10-27 加入
Next-generation therapeutics for diabetic kidney disease
7天前
已完结
Mechanisms of diabetic kidney disease and established and emerging treatments
8天前
已完结
Nonclinical Investigation of Cytokine Mitigation Strategies for T-cell–Engaging Bispecifics in the Cynomolgus Macaque
9天前
已完结
Impact of degradation in subcutaneous tissue and lymphatic fluid on absorption of Fc-fusion proteins following subcutaneous administration
14天前
已完结
Therapeutic targeting of neuroimmune mechanisms in neurodegeneration
14天前
已完结
Unlocking the potential of T cell engagers in solid tumors
29天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
29天前
已完结
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
1个月前
已完结
Targeting claudins in cancer
1个月前
已完结
皖公网安备34019202002308
